|
|
$1,020.00
|
Belarus Pharmaceuticals and Healthcare Report Q2 2013
4/24/2013 | published by: Business Monitor International
... of domestic drug demand, we note that currency devaluationwould have significantly increased the price of imported raw materials and manufacturing equipment. Atthe same time, the country’s political stance may potentially disrupt supplies of high-tech medicinescurrently ...
|
read more...
|
$1,175.00
|
Lithuania Pharmaceuticals and Healthcare Report Q2 2013
4/24/2013 | published by: Business Monitor International
... the overall potential earnings in the countryfor pharmaceutical companies. Nevertheless, niche areas, such as biopharmaceuticals, will remain ofinterest to foreign majors, also from the point of view of exports. Headline Expenditure Projections Pharmaceuticals: LTL1.74bn (US$647mn) ...
|
read more...
|
$1,175.00
|
Indonesia Pharmaceuticals and Healthcare Report Q2 2013
4/24/2013 | published by: Business Monitor International
... manufacturers and providers of medicalservices. Companies that already have a presence in the South East Asian country will have a distinctadvantage over new entrants. We note that the significant expansion of medical services in recent ...
|
read more...
|
$1,175.00
|
Puerto Rico Pharmaceuticals and Healthcare Report Q2 2013
4/24/2013 | published by: Business Monitor International
... tax increase from the local government. However, the pharmaceutical industry will remain an economic mainstay for Puerto Rico, as theincentives draw multinational drugmakers' investment - as long as the market's attractiveness continuesto offset the impact ...
|
read more...
|
$1,175.00
|
Podiatrists in the US - Industry Risk Rating Report
4/24/2013 | published by: IBISWorld
... the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), ...
|
read more...
|
$1,020.00
|
|
|
$1,020.00
|
|
|
$1,020.00
|
|
|
$1,020.00
|
|
|
$1,020.00
|
|
|
$1,020.00
|
|
|
$1,020.00
|
|
|
$1,020.00
|
|
|
$1,020.00
|
Hospitals in the US - Industry Risk Rating Report
4/24/2013 | published by: IBISWorld
... the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), ...
|
read more...
|
$1,020.00
|
United Kingdom Pharmaceuticals and Healthcare Report Q2 2013
4/24/2013 | published by: Business Monitor International
... over the five years to 2017, we project that themarket will decline in value terms, because of patent expirations and various cost-containment measuresthat include cost-effectiveness assessment of expensive treatments. Still, high per capita consumption ofpatented ...
|
read more...
|
$1,175.00
|
Dentists in the US - Industry Risk Rating Report
4/24/2013 | published by: IBISWorld
... the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), ...
|
read more...
|
$1,020.00
|
Chiropractors in the US - Industry Risk Rating Report
4/24/2013 | published by: IBISWorld
... the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), ...
|
read more...
|
$1,020.00
|
|
|
$1,020.00
|
|
|
$1,020.00
|
Czech Republic Pharmaceuticals and Healthcare Report Q2 2013
4/24/2013 | published by: Business Monitor International
... agencies and blind bidding auctions drive prices down year-onyear. The open movement of goods and services in the European Union has given rise to an arbitrageopportunity for medicines, which certain businesses have exploited. While within ...
|
read more...
|
$1,175.00
|
Kenya Pharmaceuticals and Healthcare Report Q3 2013
4/24/2013 | published by: Business Monitor International
... well as being home to the strategically important port of Mombasa. However, we caution there are weaknesses in the business environment, most notably a high level ofcorruption, which can make it difficult for both local ...
|
read more...
|
$1,175.00
|
Philippines Pharmaceuticals and Healthcare Report Q2 2013
4/24/2013 | published by: Business Monitor International
... economic stability, aswell as the eventual implementation of universal healthcare coverage. However, potential threats topolitical stability may threaten overall growth in the sector in terms of policy continuity. Headline Expenditure Projections Pharmaceuticals: PHP129.78bn (US$3.07bn) in ...
|
read more...
|
$1,175.00
|
Russia Pharmaceuticals and Healthcare Report Q2 2013
4/24/2013 | published by: Business Monitor International
... the market over the last decade has been the growthof the state's role, both in establishing an industrial policy and investing in production for the first timesince the end of the Soviet Union. Key drivers ...
|
read more...
|
$1,175.00
|
|
|
$85.00
|